DK524289D0 - Fremgangsmaade til diagnosticering for og vaccine mod mycobakterier - Google Patents

Fremgangsmaade til diagnosticering for og vaccine mod mycobakterier

Info

Publication number
DK524289D0
DK524289D0 DK524289A DK524289A DK524289D0 DK 524289 D0 DK524289 D0 DK 524289D0 DK 524289 A DK524289 A DK 524289A DK 524289 A DK524289 A DK 524289A DK 524289 D0 DK524289 D0 DK 524289D0
Authority
DK
Denmark
Prior art keywords
ism
probes
diagnostication
procedure
disease
Prior art date
Application number
DK524289A
Other languages
English (en)
Other versions
DK524289A (da
Inventor
John Hermon-Taylor
John-Jo Mcfadden
Original Assignee
Bioscience Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioscience Int Inc filed Critical Bioscience Int Inc
Publication of DK524289D0 publication Critical patent/DK524289D0/da
Publication of DK524289A publication Critical patent/DK524289A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
DK524289A 1987-04-24 1989-10-23 Fremgangsmaade til diagnosticering for og vaccine mod mycobakterier DK524289A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878709803A GB8709803D0 (en) 1987-04-24 1987-04-24 Treatment of crohn's disease &c
PCT/GB1988/000313 WO1988008456A1 (en) 1987-04-24 1988-04-22 Diagnostics and vaccines for mycobacteria in public health, medical and veterinary practice

Publications (2)

Publication Number Publication Date
DK524289D0 true DK524289D0 (da) 1989-10-23
DK524289A DK524289A (da) 1989-12-22

Family

ID=10616336

Family Applications (1)

Application Number Title Priority Date Filing Date
DK524289A DK524289A (da) 1987-04-24 1989-10-23 Fremgangsmaade til diagnosticering for og vaccine mod mycobakterier

Country Status (11)

Country Link
EP (2) EP0356450A1 (da)
JP (1) JPH03503837A (da)
AT (1) ATE131533T1 (da)
AU (1) AU624574B2 (da)
CA (1) CA1340172C (da)
DE (1) DE3854767T2 (da)
DK (1) DK524289A (da)
FI (1) FI895050A0 (da)
GB (1) GB8709803D0 (da)
NZ (1) NZ224351A (da)
WO (1) WO1988008456A1 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4976958A (en) * 1987-02-26 1990-12-11 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US4918178A (en) * 1987-10-22 1990-04-17 Wisconsin Alumni Research Foundation Test for Johne's disease
EP0345021B1 (en) * 1988-06-02 1994-04-27 Nippon Zeon Co., Ltd. Poultry mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same
FR2645878B1 (fr) * 1989-04-17 1994-02-25 Institut Nal Sante Recherc Medic Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes
CA2016553A1 (en) * 1989-05-16 1990-11-16 Dyann F. Wirth Dna hybridization probes for identification of mycobacteria
US5597911A (en) * 1989-09-06 1997-01-28 Institut Pasteur Mycobacterial nucleic acid hybridization probes and methods of use
FR2651505B1 (fr) * 1989-09-06 1994-07-22 Pasteur Institut Fragments d'acides nucleiques derives d'un genome de mycobacterie appropriee, leurs applications dans le diagnostic des infections a mycobacteries et plasmides contenant lesdits fragments.
AU631460B2 (en) 1989-09-19 1992-11-26 N.V. Innogenetics S.A. Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis
EP0419355B1 (en) * 1989-09-19 2000-02-09 N.V. Innogenetics S.A. Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis
US7083797B2 (en) 1990-09-19 2006-08-01 N.V. Innogenetics S.A. 32-kDa protein derived from Mycobacterium tuberculosis and related peptides
NZ231429A (en) * 1989-11-17 1992-12-23 Univ Massey Diagnostic probes and their use in detecting mycobacterium paratuberculosis
US5174983A (en) * 1990-09-24 1992-12-29 The United States Of America, As Represented By The Secretary Of The Navy Flame or plasma synthesis of diamond under turbulent and transition flow conditions
US5168039A (en) * 1990-09-28 1992-12-01 The Board Of Trustees Of The University Of Arkansas Repetitive DNA sequence specific for mycobacterium tuberculosis to be used for the diagnosis of tuberculosis
EP0577666B1 (en) 1991-03-25 2000-10-18 N.V. Innogenetics S.A. Polypeptides from mycobacterium paratuberculosis
FR2682967B1 (fr) * 1991-10-25 1994-01-14 Pasteur Institut Nouveau promoteur de m. paratuberculosis. son utilisation pour le clonage et l'expression de sequences nucleotidiques.
FR2683227B1 (fr) * 1991-10-31 1994-03-04 Pasteur Institut Sequences nucleotidiques hybridant avec les souches bacteriennes du complexe mycobacterium avium-intracellulare, leur utilisation comme amorces oligonucleotidiques et sondes nucleiques.
US5314801A (en) * 1992-11-06 1994-05-24 Becton, Dickinson And Company Probes to Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium paratuberculosis
GB9526178D0 (en) 1995-12-21 1996-02-21 Taylor John Hermon Novel polynuceotides and polypeptides in pathogenic mycobacteria and their use as diagnostics,vaccines and targets for chemotherapy
DE19728834C2 (de) * 1997-07-05 1999-10-21 Gerlach Gerald F Eisenreduktase
GB9806093D0 (en) 1998-03-20 1998-05-20 Taylor John Hermon Diagnostics and vaccines for mycobacterial infections of animals and humans
NZ534360A (en) * 2002-01-11 2005-10-28 Id Lelystad Instiuut Voor Dier Diagnostics and vaccines for mycobacterium paratuberculosis infections
NZ519469A (en) * 2002-06-10 2005-01-28 Agres Ltd Nucleic acid probes for detecting the presence of Mycobacterium paratuberculosis and distinguishing between cattle and sheep strains
DE10309368A1 (de) * 2002-08-06 2004-02-26 Aventis Behring Gmbh Intellectual Property/Legal Pharmazeutische Zubereitung mit RNA als Cofaktor der Hämostase
CA2617506C (en) 2005-08-09 2015-02-03 St George's Enterprises Limited Immunogenic constructs useful for treating mycobacterium avium subspecies paratuberculosis (map) infection
DE102012103730A1 (de) 2012-04-27 2013-11-14 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Nachweisverfahren für Mycobacterium avium ssp. paratuberculosis
GB201700487D0 (en) 2017-01-11 2017-02-22 Hermon-Taylor John Diagnostic

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4717653A (en) * 1981-09-25 1988-01-05 Webster John A Jr Method for identifying and characterizing organisms
FI63596C (fi) * 1981-10-16 1983-07-11 Orion Yhtymae Oy Mikrobdiagnostiskt foerfarande som grundar sig pao skiktshybridisering av nukleinsyror och vid foerfarandet anvaenda kombinationer av reagenser
DE3486467T3 (de) * 1983-01-10 2004-10-14 Gen-Probe Inc., San Diego Verfahren zum Nachweis, Identifizieren und Quantifizieren von Organismen und Viren
CA1277931C (en) * 1984-06-05 1990-12-18 Shimon Ulitzur Detection and/or identification of microorganisms in a test sample usingbioluminescence or other exogenous genetically-introduced marker
FR2565825B1 (fr) * 1984-06-15 1990-07-13 Centre Nat Rech Scient Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
US4755458A (en) * 1984-08-30 1988-07-05 Enzo Biochem, Inc. Composition and method for the detection of the presence of a polynucleotide sequence of interest
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
DE3687645T2 (de) * 1986-01-07 1993-05-27 Gen Probe Inc Verfahren der beschleunigten wiederassoziation der nukleinsaeure.
DE3627475A1 (de) * 1986-06-26 1988-01-14 Gergely Gerhard Verfahren zum herstellen eines brausegranulates, danach hergestelltes brausegranulat sowie dessen verwendung
EP0315637B1 (en) * 1986-07-25 1996-03-06 Synergen, Inc. Polypeptides useful in diagnosis of mycoplasma infections in swine and recombinant-dna methods for manufacturing same
US4906742A (en) * 1986-07-31 1990-03-06 Whitehead Institute For Biomedical Research Encoding antigens of M. Leprae
ES2112824T5 (es) * 1986-11-24 2008-03-01 Gen-Probe Incorporated Sondas de acidos nucleicos para deteccion y/o cuantificacion de organismos no virales.

Also Published As

Publication number Publication date
EP0288306A1 (en) 1988-10-26
DE3854767D1 (de) 1996-01-25
GB8709803D0 (en) 1987-05-28
EP0356450A1 (en) 1990-03-07
AU624574B2 (en) 1992-06-18
AU1628688A (en) 1988-12-02
EP0288306B1 (en) 1995-12-13
WO1988008456A1 (en) 1988-11-03
ATE131533T1 (de) 1995-12-15
DE3854767T2 (de) 1996-09-05
CA1340172C (en) 1998-12-08
FI895050A0 (fi) 1989-10-24
NZ224351A (en) 1990-12-21
DK524289A (da) 1989-12-22
JPH03503837A (ja) 1991-08-29

Similar Documents

Publication Publication Date Title
DK524289A (da) Fremgangsmaade til diagnosticering for og vaccine mod mycobakterier
WO2001062893A3 (en) Compounds and methods for diagnosis and immunotherapy of tuberculosis
Collins et al. Diagnosis and epidemiology of bovine tuberculosis using molecular biological approaches
US7709211B2 (en) Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
DE69232956T2 (de) Verbesserungen der diagnose und der prophylaxe von borrelia burgdorferi
HUP0203705A2 (hu) Vegyületek és eljárások Chlamydia-fertőzés kezelésére és diagnózisára
DK602087D0 (da) Plasmid, bakterie indeholdende plasmidet, monoklonalt antistof derfor og fremgangsmaade til identificering af haemophilus influenza
EA200100565A1 (ru) Новые стрептококковые антигены
EP0345299A1 (en) Mycobacterium tuberculosis genes encoding protein antigens
DE69636075D1 (de) Verbindungen und verfahren zur diagnose von tuberkulose
DE69942426D1 (de) Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen
WO2000005378A3 (en) Streptococcus suis vaccines and diagnostic tests
EA200000860A1 (ru) Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты)
Clayton et al. Detection and identification of Helicobacter pylori by the polymerase chain reaction.
ATE526994T1 (de) Mtb32a antigen aus mycobakterium tuberculosis mit inaktivierter protease aktivität und fusionsproteine die das antigen enthalten
Mutharia et al. Analysis of culture filtrate and cell wall-associated antigens of Mycobacterium paratuberculosis with monoclonal antibodies
CY1109210T1 (el) Διαγραφεισες αλληλουχιες στο μ. bovis bcg/m. bovis ΄η μ. tuberculosis, μεθοδος ανιχνευσεως μυκοβακτηριων που χρησιμοποιουν αυτες τις αλληλουχιες και εμβολια
NZ519053A (en) Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
AU2003208539B2 (en) Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines
KR100951057B1 (ko) 면역특이단백질 항원을 사용하는 우결핵 특이 효소면역진단키트 및 이를 이용한 우결핵 진단방법
Lopez et al. Identification of conserved antigens for early serodiagnosis of relapsing fever Borrelia
Shrivastaw et al. Quantitation of protein content by biuret method during production of yellow fever vaccine
DE69535156D1 (de) Verfahren und zusammensetzungen zur diagnose von rochalimaea henselae und rochalimaea quintana infektion
BR9509275A (pt) Processos para produzir bactéria helicobacter tendo propriedades antigênicas aumentadas testar um agente antimicrobiano potencial detectar anticorpos de um hospedeiro para bactéria helicobacter e bactéria helicobacter em um animal ou amostra biológica deste produzir anticorpos antibacterianos e estimular e estimular uma imunoresposta em um animal bactéria helicobacter vacina e estojo de teste diagnóstico para detectar um hospedeiro de anticorpos para bactéria helicobacter ou para detectar bactéria helicobacter
ATE366583T1 (de) Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment